Cancer Biological Therapy Market size worth $100bn by 2023 (1) - PowerPoint PPT Presentation

Loading...

PPT – Cancer Biological Therapy Market size worth $100bn by 2023 (1) PowerPoint presentation | free to download - id: 82c8e7-NmQzZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Cancer Biological Therapy Market size worth $100bn by 2023 (1)

Description:

Cancer Biological Therapy Market size was USD 61.3 billion in 2015, with revenue forecast to cross USD 100 billion, at upwards of 6% growth from 2016 to 2023. – PowerPoint PPT presentation

Number of Views:3

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Cancer Biological Therapy Market size worth $100bn by 2023 (1)


1
Cancer Biological Therapy Market size worth
100bn by 2023
2
Cancer Biological Therapy Market size worth
100bn by 2023
  • Cancer Biological Therapy Market size was USD
    61.3 billion in 2015, with revenue forecast to
    cross USD 100 billion, at upwards of 6 growth
    from 2016 to 2023.
  • Rise in incidence rate of various cancers and
    growing adoption of biological therapy will drive
    the growth of the global cancer biological
    therapy market.
  • According to WHO, the number of new cancer cases
    is projected to rise 70 in the coming two
    decades, mainly due to increased use of tobacco
    and alcohol consumption. 
  • As per NCI, an estimated 16,85,210 new cases will
    be diagnosed in 2016, and about 5,95,690
    individuals will succumb to the disease in the
    U.S.
  • Growing global geriatric population is predicted
    to boost biological cancer therapy market size
    owing to link between new cases and old age.
    Elderly population is more prone to the disease,
    and as per the ACS, 86 of cases in the U.S. were
    recorded in individuals aged 50 and above.
  • https//www.gminsights.com/industry-analysis/cance
    r-biological-therapy-market

3
Continue.....
  • This is due to accumulation of mutations in aged
    individuals body over time coupled with a
    reduction in the DNA mismatch repair process in
    hematopoietic stem cells (HSC).
  • The high treatment cost of oncology therapy is
    primarily due to high cost of drug development.
    Millions of dollars are spent in identifying or
    designing a drug, obtaining preclinical data and
    clinical trials.
  • It is estimated that each drug costs about USD
    1.2 to USD 1.3 billion.
  • Monopoly is another factor contributing to high
    costs.
  • There are very few companies engaged in the
    manufacture of drugs resulting in reduced
    competition and higher prices, which restrains
    the global cancer biologic therapy market.
  • Cancer vaccines market was over USD 1.9 billion
    in 2015. Approval of the first vaccine
    sipuleucel-T (Provenge) for metastatic prostate
    cancer by the FDA will boost growth in the
    immunotherapy segment.
  • Get more detail _at_ https//www.gminsights.com/indus
    try-analysis/cancer-biological-therapy-market

4
U.S. Cancer Biological Therapy Market size, by
product, 2012 - 2023 (USD Million)

https//www.gminsights.com/request-sample/detail/6
76
5
360 Analysis
  • Product Analysis
  • Monoclonal antibodies market size was over USD 21
    billion in 2015. Antibody therapy is the most
    successful and important approach for treatment
    of hematological malignance and  solid tumors.
    Bispecific monoclonal antibodies are anticipated
    to grow at  6.5 CAGR from 2016 to 2023.
  • Regional Analysis
  • Increased public funding for RD and other
    government initiatives is expected to drive
    growth in North America over the forecast period.
    Germany cancer biological therapy market size was
    over USD 4.3 billion in 2015. It is expected to
    continue revenue share dominance due to increased
    prevalence and favorable public reimbursement and
    insurance policies.
  • Competitive Market Share
  • Novartis International Ag, Amgen Inc., Merck
    Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline
    Plc, F. Hoffmann-La Roche AG, Eli Lilly, Seattle
    Genetics, Inc., Spectrum Pharmaceuticals, Inc.,
    Celgene Corporation are some notable companies
    vying for global cancer biological therapy market
    share.
  • Get more detail _at_ https//www.gminsights.com/indus
    try-analysis/cancer-biological-therapy-market


6

Latest Research Report On Cancer Biological
Therapy Market _at_ https//www.gminsights.com/indust
ry-analysis/cancer-biological-therapy-market
Download Latest Report PDF _at_ https//www.gminsig
hts.com/request-sample/detail/676
7
Stay In Touch You can visit us at
www.gminsights.com
About PowerShow.com